152 related articles for article (PubMed ID: 38031759)
1. Comorbidity indices for prognostic evaluation in multiple myeloma: a comprehensive evaluation of the Revised Myeloma Comorbidity Index and other comorbidity indices with pro- and retrospective applications.
Schoeller K; Ihorst G; Reinhardt H; Holler M; Scheubeck S; Herget G; Wäsch R; Engelhardt M
Haematologica; 2024 Apr; 109(4):1279-1284. PubMed ID: 38031759
[No Abstract] [Full Text] [Related]
2. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.
Engelhardt M; Domm AS; Dold SM; Ihorst G; Reinhardt H; Zober A; Hieke S; Baayen C; Müller SJ; Einsele H; Sonneveld P; Landgren O; Schumacher M; Wäsch R
Haematologica; 2017 May; 102(5):910-921. PubMed ID: 28154088
[TBL] [Abstract][Full Text] [Related]
3. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
[TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of Common Comorbidity Scores and Freiburger Comorbidity Index as Prognostic Variables in a Real Life Multiple Myeloma Population.
Onec B; Okutan H; Albayrak M; Can ES; Aslan V; Soyer Kosemehmetoglu O; Unver Koluman B
Indian J Hematol Blood Transfus; 2016 Dec; 32(4):424-430. PubMed ID: 27812251
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort.
Scheubeck S; Ihorst G; Schoeller K; Holler M; Möller MD; Reinhardt H; Wäsch R; Engelhardt M
Cancer; 2021 Sep; 127(18):3422-3436. PubMed ID: 34061991
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Freiburg and Charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
Kim SM; Kim MJ; Jung HA; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
Biomed Res Int; 2014; 2014():437852. PubMed ID: 25114902
[TBL] [Abstract][Full Text] [Related]
7. Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial.
Dold SM; Möller MD; Ihorst G; Langer C; Pönisch W; Mügge LO; Knop S; Jung J; Greil C; Wäsch R; Engelhardt M
Haematologica; 2021 Mar; 106(3):875-880. PubMed ID: 32414853
[No Abstract] [Full Text] [Related]
8. Prognostic effect of comorbidity indices in elderly patients with multiple myeloma.
Bila J; Jelicic J; Djurasinovic V; Vukovic V; Sretenovic A; Andjelic B; Antic D; Todorovic M; Mihaljevic B
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):416-9. PubMed ID: 25873436
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score.
Kleber M; Ihorst G; Terhorst M; Koch B; Deschler B; Wäsch R; Engelhardt M
Blood Cancer J; 2011 Sep; 1(9):e35. PubMed ID: 22829196
[TBL] [Abstract][Full Text] [Related]
10. Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal.
Kleber M; Ihorst G; Udi J; Koch B; Wäsch R; Engelhardt M
Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):38-48. PubMed ID: 22054851
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity and prognostic indices do not improve the 5-year mortality prediction of components of comprehensive geriatric assessment in hospitalized older patients.
Martínez-Velilla N; Cambra-Contin K; Ibáñez-Beroiz B
BMC Geriatr; 2014 May; 14():64. PubMed ID: 24886561
[TBL] [Abstract][Full Text] [Related]
12. A comparison of three different approaches to defining frailty in older patients with multiple myeloma.
Isaacs A; Fiala M; Tuchman S; Wildes TM
J Geriatr Oncol; 2020 Mar; 11(2):311-315. PubMed ID: 31326393
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome.
Kleber M; Ihorst G; Gross B; Koch B; Reinhardt H; Wäsch R; Engelhardt M
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):541-51. PubMed ID: 23810244
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
[TBL] [Abstract][Full Text] [Related]
15. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
[TBL] [Abstract][Full Text] [Related]
16. The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.
Sim S; Kalff A; Tuch G; Mollee P; Ho PJ; Harrison S; Gibbs S; Prince HM; Spencer A; Joshua D; Lee C; Ling S; Murphy N; Szabo F; Szer J; Weber N; Ward C; Talaulikar D; Zannettino A; Quach H
Intern Med J; 2023 May; 53(5):819-824. PubMed ID: 36880355
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis.
Silverman SL; Wang A; Cheng L; Yang Y; Libanati C; Geller M; Grauer A; Nevitt M; Revicki D; Viswanathan HN
Osteoporos Int; 2016 Jan; 27(1):75-80. PubMed ID: 26174879
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Comorbidity Indices for a Study of Patient Outcomes Following Cervical Decompression Surgery: A Retrospective Cohort Study.
Oichi T; Oshima Y; Takeshita K; Chikuda H; Tanaka S
Spine (Phila Pa 1976); 2015 Dec; 40(24):1941-7. PubMed ID: 26655806
[TBL] [Abstract][Full Text] [Related]
19. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients.
Ríos-Tamayo R; Sáinz J; Martínez-López J; Puerta JM; Chang DY; Rodríguez T; Garrido P; de Veas JL; Romero A; Moratalla L; López-Fernández E; González PA; Sánchez MJ; Jiménez-Moleón JJ; Jurado M; Lahuerta JJ
Am J Hematol; 2016 Jul; 91(7):700-4. PubMed ID: 27074204
[TBL] [Abstract][Full Text] [Related]
20. Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study.
Moreno Berggren D; Kjellander M; Backlund E; Engvall M; Garelius H; Lorenz F; Nilsson L; Rasmussen B; Lehmann S; Hellström-Lindberg E; Jädersten M; Ungerstedt J; Ejerblad E
Br J Haematol; 2021 Feb; 192(3):474-483. PubMed ID: 32501529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
